The risk or severity of adverse effects can be increased when oxycodone is combined with triprolidine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when methylene blue is combined with mianserin.


The risk or severity of adverse effects can be increased when propantheline is combined with oxybutynin.


The risk or severity of adverse effects can be increased when lisinopril is combined with apraclonidine.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Torasemide.


The risk or severity of adverse effects can be increased when quetiapine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when acemetacin is combined with loteprednol.


The risk or severity of adverse effects can be increased when miconazole is combined with diltiazem.


The risk or severity of adverse effects can be increased when suprofen is combined with estrone.


The risk or severity of adverse effects can be increased when cilnidipine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when dibucaine is combined with paroxetine.


The risk or severity of adverse effects can be increased when estazolam is combined with zotepine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when oxybutynin is combined with tubocurarine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with budesonide.


The risk or severity of adverse effects can be increased when enalapril is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when Normethadone is combined with tizanidine.


The risk or severity of adverse effects can be increased when Normethadone is combined with furosemide.


The risk or severity of adverse effects can be increased when paroxetine is combined with clomipramine.


The risk or severity of adverse effects can be increased when estazolam is combined with MELPERONE.


The risk or severity of adverse effects can be increased when bepridil is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when imipramine is combined with Indacaterol.


The risk or severity of adverse effects can be increased when D-mannitol is combined with apraclonidine.


The risk or severity of adverse effects can be increased when D-mannitol is combined with Telmisartan.


The risk or severity of adverse effects can be increased when metoprolol is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when flurazepam is combined with clozapine.


The risk or severity of adverse effects can be increased when Dabigatran etexilate is combined with meperidine.


The risk or severity of adverse effects can be increased when metoprolol is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when metoprolol is combined with bumetanide.


The risk or severity of adverse effects can be increased when Trospium is combined with methadone.


The risk or severity of adverse effects can be increased when Mometasone is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when orphenadrine is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when protriptyline is combined with Phenelzine.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when apraclonidine is combined with nadolol.


The risk or severity of adverse effects can be increased when Trospium is combined with oxybutynin.


The risk or severity of adverse effects can be increased when baclofen is combined with topiramate.


The risk or severity of adverse effects can be increased when diflorasone is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Normethadone is combined with metolazone.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with Echothiophate.


The risk or severity of adverse effects can be increased when halothane is combined with apraclonidine.


The risk or severity of adverse effects can be increased when halothane is combined with Telmisartan.


The risk or severity of adverse effects can be increased when halothane is combined with Desloratadine.


The risk or severity of adverse effects can be increased when halothane is combined with methyldopa.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Melatonin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when acemetacin is combined with medrysone.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when MAGNESIUM OXIDE is combined with misoprostol.


The risk or severity of adverse effects can be increased when lorazepam is combined with clomipramine.


The risk or severity of adverse effects can be increased when Tramadol is combined with indapamide.


The risk or severity of adverse effects can be increased when risperidone is combined with cetirizine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when nilvadipine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with digitoxin.


The risk or severity of adverse effects can be increased when prilocaine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when irbesartan is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with cisplatin.


The risk or severity of adverse effects can be increased when irbesartan is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when flurazepam is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when EDOXABAN is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when sotalol is combined with cilazapril.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with acebutolol.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when dipyridamole is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when sulindac is combined with betamethasone.


The risk or severity of adverse effects can be increased when MELPERONE is combined with tiagabine.


The risk or severity of adverse effects can be increased when MELPERONE is combined with zonisamide.


The risk or severity of adverse effects can be increased when meprobamate is combined with lidocaine.


The risk or severity of adverse effects can be increased when Ticagrelor is combined with Apixaban.


The risk or severity of adverse effects can be increased when lidocaine is combined with baclofen.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with potassium ion.


The risk or severity of adverse effects can be increased when benzocaine is combined with lithium ion.


The risk or severity of adverse effects can be increased when dyclonine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with formestane.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when ketorolac is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when trandolapril is combined with papaverine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Caspofungin is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when Icatibant is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when methazolamide is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when codeine is combined with butorphanol.


The risk or severity of adverse effects can be increased when risperidone is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Icatibant is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when Pramocaine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when nitrendipine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Olsalazine is combined with formestane.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when selegiline is combined with dipivefrin.


The risk or severity of adverse effects can be increased when loxapine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when loxapine is combined with bupivacaine.


The risk or severity of adverse effects can be increased when glutethimide is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when loxapine is combined with Etomidate.


The risk or severity of adverse effects can be increased when bupivacaine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when topiramate is combined with meclizine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with dextromethorphan.


The risk or severity of adverse effects can be increased when alclometasone is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when cerulenin is combined with felodipine.


The risk or severity of adverse effects can be increased when cerulenin is combined with Efonidipine.


The risk or severity of adverse effects can be increased when cerulenin is combined with Lacidipine.


The risk or severity of adverse effects can be increased when cerulenin is combined with Benidipine.


The risk or severity of adverse effects can be increased when cerulenin is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when cerulenin is combined with cilnidipine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with brotizolam.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Torasemide.


The risk or severity of adverse effects can be increased when Asenapine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when butorphanol is combined with etizolam.


The risk or severity of adverse effects can be increased when bupivacaine is combined with prazepam.


The risk or severity of adverse effects can be increased when indomethacin is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when bupivacaine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when levorphanol is combined with dantrolene.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when loxapine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when triprolidine is combined with citalopram.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when clozapine is combined with trandolapril.


The risk or severity of adverse effects can be increased when Rufinamide is combined with mesoridazine.


The risk or severity of adverse effects can be increased when pergolide is combined with raloxifene.


The risk or severity of adverse effects can be increased when secobarbital is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Rufinamide is combined with maprotiline.


The risk or severity of adverse effects can be increased when loxapine is combined with scopolamine.


The risk or severity of adverse effects can be increased when Agomelatine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with cinoxacin.


The risk or severity of adverse effects can be increased when nicergoline is combined with ROLITETRACYCLINE.


The risk or severity of adverse effects can be increased when Agomelatine is combined with duloxetine.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with quetiapine.


The risk or severity of adverse effects can be increased when Halazepam is combined with amoxapine.


The risk or severity of adverse effects can be increased when Halazepam is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when propofol is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when codeine is combined with Torasemide.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when thioridazine is combined with cetirizine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when nitrendipine is combined with tizanidine.


The risk or severity of adverse effects can be increased when olanzapine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when tetracaine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Calcium citrate is combined with Calcifediol.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when sulconazole is combined with nitrendipine.


The risk or severity of adverse effects can be increased when lithium ion is combined with Desloratadine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with bromazepam.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with levorphanol.


The risk or severity of adverse effects can be increased when methadone is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when cabergoline is combined with Iloperidone.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with cabergoline.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with halothane.


The risk or severity of adverse effects can be increased when sertraline is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with zotepine.


The risk or severity of adverse effects can be increased when tolnaftate is combined with nimesulide.


The risk or severity of adverse effects can be increased when clorazepate is combined with diazepam.


The risk or severity of adverse effects can be increased when amobarbital is combined with Perospirone.


The risk or severity of adverse effects can be increased when estazolam is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Propacetamol.


The risk or severity of adverse effects can be increased when clonazepam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with nadolol.


The risk or severity of adverse effects can be increased when Vilazodone is combined with quetiapine.


The risk or severity of adverse effects can be increased when meperidine is combined with furosemide.


The risk or severity of adverse effects can be increased when methylergonovine is combined with RUCAPARIB.


The risk or severity of adverse effects can be increased when nitrazepam is combined with dyclonine.


The risk or severity of adverse effects can be increased when olanzapine is combined with thiopental.


The risk or severity of adverse effects can be increased when nitrazepam is combined with propoxyphene.


The risk or severity of adverse effects can be increased when cyclophosphamide is combined with amiodarone.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Lomitapide.


The risk or severity of adverse effects can be increased when bromocriptine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with topiramate.


The risk or severity of adverse effects can be increased when ramipril is combined with benazepril.


The risk or severity of adverse effects can be increased when diazepam is combined with trazodone.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with tizanidine.


The risk or severity of adverse effects can be increased when ipratropium is combined with Trospium.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with furosemide.


The risk or severity of adverse effects can be increased when Eluxadoline is combined with Methylnaltrexone.


The risk or severity of adverse effects can be increased when propofol is combined with METAXALONE.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when scopolamine is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with zopiclone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Tolcapone is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Tolcapone is combined with felodipine.


The risk or severity of adverse effects can be increased when oxycodone is combined with Pramocaine.


The risk or severity of adverse effects can be increased when methyldopa is combined with Riociguat.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with procarbazine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with phenytoin.


The risk or severity of adverse effects can be increased when alclofenac is combined with fluocinonide.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with prednisone.


The risk or severity of adverse effects can be increased when Rotigotine is combined with terazosin.


The risk or severity of adverse effects can be increased when Nepafenac is combined with paramethasone.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when Nepafenac is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when propranolol is combined with losartan.


The risk or severity of adverse effects can be increased when prazosin is combined with fosinopril.


The risk or severity of adverse effects can be increased when mecamylamine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when bromazepam is combined with imipramine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Nepafenac is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when dapsone is combined with zopiclone.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with dexamethasone.


The risk or severity of adverse effects can be increased when pirenzepine is combined with pentazocine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when buspirone is combined with meclizine.


The risk or severity of adverse effects can be increased when buspirone is combined with risperidone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with oxprenolol.


The risk or severity of adverse effects can be increased when bromazepam is combined with loratadine.


The risk or severity of adverse effects can be increased when nefazodone is combined with periciazine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with antipyrine.


The risk or severity of adverse effects can be increased when metaraminol is combined with terbutaline.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when THYMOL is combined with Clevidipine.


The risk or severity of adverse effects can be increased when losartan is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Remoxipride.


The risk or severity of adverse effects can be increased when isradipine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when triamcinolone is combined with memantine.


The risk or severity of adverse effects can be increased when triamcinolone is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when propranolol is combined with enalapril.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with levodopa.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when CALCIUM GLUCONATE is combined with Doxercalciferol.


The risk or severity of adverse effects can be increased when estazolam is combined with amoxapine.


The risk or severity of adverse effects can be increased when itraconazole is combined with vinorelbine.


The risk or severity of adverse effects can be increased when CALCIUM GLUCONATE is combined with ergocalciferol.


The risk or severity of adverse effects can be increased when amiodarone is combined with Carbetocin.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when flurazepam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when thioridazine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with oxprenolol.


The risk or severity of adverse effects can be increased when nalbuphine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with prazepam.


The risk or severity of adverse effects can be increased when nalbuphine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when nalbuphine is combined with levodopa.


The risk or severity of adverse effects can be increased when barnidipine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Ramelteon.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when morphine is combined with Nebivolol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when enflurane is combined with thiamylal.


The risk or severity of adverse effects can be increased when ipratropium is combined with Pentolinium.


The risk or severity of adverse effects can be increased when ketorolac is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when enflurane is combined with halothane.


The risk or severity of adverse effects can be increased when indomethacin is combined with alclometasone.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Ticagrelor.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when perphenazine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with baclofen.


The risk or severity of adverse effects can be increased when nalbuphine is combined with procaine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with trimipramine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with propofol.


The risk or severity of adverse effects can be increased when perphenazine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when diazepam is combined with dantrolene.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when perphenazine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when butalbital is combined with efavirenz.


The risk or severity of adverse effects can be increased when Carbetocin is combined with selegiline.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with amitriptyline.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Tolcapone.


The risk or severity of adverse effects can be increased when diazepam is combined with estazolam.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with halcinonide.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with quinapril.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with difluprednate.


The risk or severity of adverse effects can be increased when thiopental is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Asenapine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when antipyrine is combined with triamcinolone.


The risk or severity of adverse effects can be increased when mecamylamine is combined with quetiapine.


The risk or severity of adverse effects can be increased when Halobetasol is combined with mefloquine.


The risk or severity of adverse effects can be increased when morphine is combined with perphenazine.


The risk or severity of adverse effects can be increased when alprazolam is combined with ethosuximide.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with dantrolene.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Olopatadine.


The risk or severity of adverse effects can be increased when alprazolam is combined with thiopental.


The risk or severity of adverse effects can be increased when Aclidinium is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when resveratrol is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when metolazone is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when perphenazine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when ketorolac is combined with sulindac.


The risk or severity of adverse effects can be increased when perphenazine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with benazepril.


The risk or severity of adverse effects can be increased when meperidine is combined with enflurane.


The risk or severity of adverse effects can be increased when clorazepate is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when ketorolac is combined with chloroquine.


The risk or severity of adverse effects can be increased when brotizolam is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when isradipine is combined with methyldopa.


The risk or severity of adverse effects can be increased when isradipine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when isradipine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with nimodipine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with levorphanol.


The risk or severity of adverse effects can be increased when gabapentin is combined with Fospropofol.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Normethadone.


The risk or severity of adverse effects can be increased when meprobamate is combined with ondansetron.


The risk or severity of adverse effects can be increased when salicylic acid is combined with nimodipine.


The risk or severity of adverse effects can be increased when meprobamate is combined with tiagabine.


The risk or severity of adverse effects can be increased when thiopental is combined with baclofen.


The risk or severity of adverse effects can be increased when salicylic acid is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with Eplerenone.


The risk or severity of adverse effects can be increased when meprobamate is combined with zonisamide.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when clomipramine is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when decamethonium is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when ipratropium is combined with hydromorphone.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Articaine.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Droxicam.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when cocaine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Sorafenib is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Tixocortol is combined with fleroxacin.


The risk or severity of adverse effects can be increased when prilocaine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when labetalol is combined with cilazapril.


The risk or severity of adverse effects can be increased when Halazepam is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Torasemide is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when difluprednate is combined with Deferasirox.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when oxazepam is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with Metipranolol.


The risk or severity of adverse effects can be increased when methocarbamol is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when clozapine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when clozapine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when pimozide is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Torasemide is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Flibanserin.


The risk or severity of adverse effects can be increased when thiopental is combined with oxprenolol.


The risk or severity of adverse effects can be increased when nitric oxide is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when brotizolam is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when cetirizine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when desipramine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when SOMATOSTATIN is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when lisinopril is combined with Naftifine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with haloperidol.


The risk or severity of adverse effects can be increased when Difenoxin is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when procaine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when nimesulide is combined with DESONIDE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with terazosin.


The risk or severity of adverse effects can be increased when Telmisartan is combined with tolmetin.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when prilocaine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when tacrolimus is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with citalopram.


The risk or severity of adverse effects can be increased when thioridazine is combined with papaverine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with cetirizine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with fenoldopam.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with protriptyline.


The risk or severity of adverse effects can be increased when terbinafine is combined with cilnidipine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with indapamide.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with maprotiline.


The risk or severity of adverse effects can be increased when cabergoline is combined with pimozide.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when clozapine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when thiothixene is combined with dantrolene.


The risk or severity of adverse effects can be increased when sumatriptan is combined with reserpine.


The risk or severity of adverse effects can be increased when manidipine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when meprobamate is combined with topiramate.


The risk or severity of adverse effects can be increased when lorazepam is combined with Remoxipride.


The risk or severity of adverse effects can be increased when thalidomide is combined with labetalol.


The risk or severity of adverse effects can be increased when Tramadol is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with ticlopidine.


The risk or severity of adverse effects can be increased when tetracaine is combined with etizolam.


The risk or severity of adverse effects can be increased when lorazepam is combined with Eszopiclone.


The risk or severity of adverse effects can be increased when thalidomide is combined with doxazosin.


The risk or severity of adverse effects can be increased when procarbazine is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when lorazepam is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Tramadol is combined with amisulpride.


The risk or severity of adverse effects can be increased when thalidomide is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when buspirone is combined with flunarizine.


The risk or severity of adverse effects can be increased when cabergoline is combined with duloxetine.


The risk or severity of adverse effects can be increased when buspirone is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when procaine is combined with clonazepam.


The risk or severity of adverse effects can be increased when epirizole is combined with alclometasone.


The risk or severity of adverse effects can be increased when Metixene is combined with oxycodone.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with benzocaine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with vigabatrin.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with apraclonidine.


The risk or severity of adverse effects can be increased when duloxetine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Halazepam is combined with Pramocaine.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Articaine.


The risk or severity of adverse effects can be increased when benazepril is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with maprotiline.


The risk or severity of adverse effects can be increased when Butethal is combined with MELPERONE.


The risk or severity of adverse effects can be increased when halothane is combined with Retigabine.


The risk or severity of adverse effects can be increased when aspirin is combined with loteprednol.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with meclizine.


The risk or severity of adverse effects can be increased when thioridazine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when mepivacaine is combined with dantrolene.


The risk or severity of adverse effects can be increased when secobarbital is combined with Normethadone.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when methocarbamol is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with tetracaine.


The risk or severity of adverse effects can be increased when alprazolam is combined with amoxapine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with bupivacaine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with morphine.


The risk or severity of adverse effects can be increased when metaproterenol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when cetirizine is combined with tiagabine.


The risk or severity of adverse effects can be increased when cetirizine is combined with zonisamide.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when clonazepam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with midazolam.


The risk or severity of adverse effects can be increased when Limaprost is combined with tirofiban.


The risk or severity of adverse effects can be increased when naratriptan is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when zopiclone is combined with tiapride.


The risk or severity of adverse effects can be increased when imipramine is combined with acebutolol.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when nimodipine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Propacetamol is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when Clofarabine is combined with spironolactone.


The risk or severity of adverse effects can be increased when Olopatadine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when fenoldopam is combined with imipramine.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with dantrolene.


The risk or severity of adverse effects can be increased when benzoic acid is combined with cinnarizine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Pipamperone.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with tubocurarine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with brotizolam.


The risk or severity of adverse effects can be increased when butabarbital is combined with felbamate.


The risk or severity of adverse effects can be increased when PERHEXILINE is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when metolazone is combined with Aliskiren.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Levocetirizine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when amifostine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with diltiazem.


The risk or severity of adverse effects can be increased when docetaxel is combined with topotecan.


The risk or severity of adverse effects can be increased when Tianeptine is combined with Salbutamol.


The risk or severity of adverse effects can be increased when docetaxel is combined with 6-Mercaptopurine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with triazolam.


The risk or severity of adverse effects can be increased when fenoldopam is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when moclobemide is combined with Perospirone.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Salbutamol.


The risk or severity of adverse effects can be increased when Arotinolol is combined with timolol.


The risk or severity of adverse effects can be increased when butalbital is combined with maprotiline.


The risk or severity of adverse effects can be increased when Naftifine is combined with cinnarizine.


The risk or severity of adverse effects can be increased when midazolam is combined with Articaine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with mecamylamine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with METAXALONE.


The risk or severity of adverse effects can be increased when pargyline is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when captopril is combined with floctafenine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Mometasone.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with zafirlukast.


The risk or severity of adverse effects can be increased when promazine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when carprofen is combined with DESONIDE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with vincristine.


The risk or severity of adverse effects can be increased when reserpine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when promazine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with DESONIDE.


The risk or severity of adverse effects can be increased when Talniflumate is combined with Icatibant.


The risk or severity of adverse effects can be increased when proparacaine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when timolol is combined with cilazapril.


The risk or severity of adverse effects can be increased when cocaine is combined with brotizolam.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with meperidine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Articaine.


The risk or severity of adverse effects can be increased when codeine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with indapamide.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with pentazocine.


The risk or severity of adverse effects can be increased when methysergide is combined with progesterone.


The risk or severity of adverse effects can be increased when suprofen is combined with oxaprozin.


The risk or severity of adverse effects can be increased when sulpiride is combined with Butethal.


The risk or severity of adverse effects can be increased when sulpiride is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when aspirin is combined with fluocinonide.


The risk or severity of adverse effects can be increased when paramethasone is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when Masoprocol is combined with alclofenac.


The risk or severity of adverse effects can be increased when paramethasone is combined with malathion.


The risk or severity of adverse effects can be increased when niflumic acid is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when Remoxipride is combined with clidinium.


The risk or severity of adverse effects can be increased when Olmesartan is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Tapentadol is combined with Conivaptan.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with resveratrol.


The risk or severity of adverse effects can be increased when Eprosartan is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when nicergoline is combined with buprenorphine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when atorvastatin is combined with spironolactone.


The risk or severity of adverse effects can be increased when meperidine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Arotinolol is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with papaverine.


The risk or severity of adverse effects can be increased when Normethadone is combined with amitriptyline.


The risk or severity of adverse effects can be increased when enalapril is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when nefazodone is combined with procarbazine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with prednisone.


The risk or severity of adverse effects can be increased when Trospium is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when butabarbital is combined with zonisamide.


The risk or severity of adverse effects can be increased when lorazepam is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when bromocriptine is combined with phentolamine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when estrone is combined with edrophonium.


The risk or severity of adverse effects can be increased when lorazepam is combined with baclofen.


The risk or severity of adverse effects can be increased when bromocriptine is combined with furosemide.


The risk or severity of adverse effects can be increased when bromocriptine is combined with daunorubicin.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when fenoldopam is combined with nifedipine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Vilanterol.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with fluocinonide.


The risk or severity of adverse effects can be increased when haloperidol is combined with carisoprodol.


The risk or severity of adverse effects can be increased when sulindac is combined with chloroquine.


The risk or severity of adverse effects can be increased when diflorasone is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when olanzapine is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when Icatibant is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when HEROIN is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when HEROIN is combined with Ramelteon.


The risk or severity of adverse effects can be increased when codeine is combined with midazolam.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with penbutolol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with glutethimide.


The risk or severity of adverse effects can be increased when loteprednol is combined with norfloxacin.


The risk or severity of adverse effects can be increased when ketamine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when protriptyline is combined with Cariprazine.


The risk or severity of adverse effects can be increased when Pregabalin is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when Milnacipran is combined with Perospirone.


The risk or severity of adverse effects can be increased when orphenadrine is combined with citalopram.


The risk or severity of adverse effects can be increased when ketamine is combined with bromazepam.


The risk or severity of adverse effects can be increased when loteprednol is combined with Echothiophate.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when haloperidol is combined with benzocaine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when amphotericin b is combined with acetyldigitoxin.


The risk or severity of adverse effects can be increased when halothane is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Sacubitril is combined with alclofenac.


The risk or severity of adverse effects can be increased when promazine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when amphotericin b is combined with trandolapril.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when valsartan is combined with Propacetamol.


The risk or severity of adverse effects can be increased when ketamine is combined with benzocaine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when ketamine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Normethadone is combined with fexofenadine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with bumetanide.


The risk or severity of adverse effects can be increased when Butethal is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when docetaxel is combined with dacarbazine.


The risk or severity of adverse effects can be increased when docetaxel is combined with temozolomide.


The risk or severity of adverse effects can be increased when docetaxel is combined with 5-Aminolevulinic acid.


The risk or severity of adverse effects can be increased when methysergide is combined with bifonazole.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when trimipramine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Toloxatone is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when Toloxatone is combined with Vilanterol.


The risk or severity of adverse effects can be increased when Halazepam is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when norfloxacin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when glutethimide is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when clomipramine is combined with acebutolol.


The risk or severity of adverse effects can be increased when LISURIDE is combined with gemfibrozil.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when loxapine is combined with haloperidol.


The risk or severity of adverse effects can be increased when LISURIDE is combined with docetaxel.


The risk or severity of adverse effects can be increased when spironolactone is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when nilvadipine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when hydromorphone is combined with butamben.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with carprofen.


The risk or severity of adverse effects can be increased when sulfanilamide is combined with atorvastatin.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Salsalate.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Lurasidone is combined with bupivacaine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Etomidate.


The risk or severity of adverse effects can be increased when lidocaine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with bicalutamide.


The risk or severity of adverse effects can be increased when bromocriptine is combined with rabeprazole.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when butorphanol is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when diclofenac is combined with Propacetamol.


The risk or severity of adverse effects can be increased when etizolam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Icatibant is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when Phenelzine is combined with metaproterenol.


The risk or severity of adverse effects can be increased when Icatibant is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with risperidone.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with methadone.


The risk or severity of adverse effects can be increased when lisinopril is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when doxazosin is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when zaleplon is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when ipratropium is combined with cyclopentolate.


The risk or severity of adverse effects can be increased when Olsalazine is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Melatonin is combined with prazepam.


The risk or severity of adverse effects can be increased when Flupentixol is combined with procaine.


The risk or severity of adverse effects can be increased when Etomidate is combined with triprolidine.


The risk or severity of adverse effects can be increased when Etomidate is combined with methocarbamol.


The risk or severity of adverse effects can be increased when indomethacin is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when oxycodone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Ramelteon.


The risk or severity of adverse effects can be increased when methylergonovine is combined with daunorubicin.


The risk or severity of adverse effects can be increased when Fosamprenavir is combined with Flibanserin.


The risk or severity of adverse effects can be increased when etizolam is combined with venlafaxine.


The risk or severity of adverse effects can be increased when etizolam is combined with clemastine.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Tramadol is combined with mesoridazine.


The risk or severity of adverse effects can be increased when imipramine is combined with prazosin.


The risk or severity of adverse effects can be increased when chloroquine is combined with diflunisal.


The risk or severity of adverse effects can be increased when Icatibant is combined with Tixocortol.


The risk or severity of adverse effects can be increased when clomipramine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when leflunomide is combined with desoximetasone.


The risk or severity of adverse effects can be increased when pramipexole is combined with nadolol.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with zotepine.


The risk or severity of adverse effects can be increased when ondansetron is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with indapamide.


The risk or severity of adverse effects can be increased when pentazocine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with ramipril.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with valsartan.


The risk or severity of adverse effects can be increased when procyclidine is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when propantheline is combined with oxycodone.


The risk or severity of adverse effects can be increased when Articaine is combined with tiagabine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with METAXALONE.


The risk or severity of adverse effects can be increased when phenytoin is combined with duloxetine.


The risk or severity of adverse effects can be increased when secobarbital is combined with pimozide.


The risk or severity of adverse effects can be increased when Melatonin is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when ropinirole is combined with bupropion.


The risk or severity of adverse effects can be increased when Salsalate is combined with diflorasone.


The risk or severity of adverse effects can be increased when midazolam is combined with prazepam.


The risk or severity of adverse effects can be increased when propofol is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when nicergoline is combined with TROLEANDOMYCIN.


The risk or severity of adverse effects can be increased when bupivacaine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when propofol is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with alclometasone.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when pentamidine is combined with barnidipine.


The risk or severity of adverse effects can be increased when clomipramine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with oxaprozin.


The risk or severity of adverse effects can be increased when risperidone is combined with dibucaine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with trimipramine.


The risk or severity of adverse effects can be increased when rapamycin is combined with rescinnamine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when floctafenine is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when quazepam is combined with Articaine.


The risk or severity of adverse effects can be increased when Pizotifen is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when thiothixene is combined with butamben.


The risk or severity of adverse effects can be increased when protriptyline is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Conivaptan is combined with methyldopa.


The risk or severity of adverse effects can be increased when HEROIN is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when etodolac is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with zotepine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Efonidipine is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when Phenelzine is combined with doxepin.


The risk or severity of adverse effects can be increased when docetaxel is combined with Belinostat.


The risk or severity of adverse effects can be increased when Etomidate is combined with amisulpride.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with clomipramine.


The risk or severity of adverse effects can be increased when clonazepam is combined with paroxetine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when sulconazole is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when Etomidate is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when temazepam is combined with zaleplon.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Retigabine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with protriptyline.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with cetirizine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with glutethimide.


The risk or severity of adverse effects can be increased when amobarbital is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Melatonin is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with citalopram.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with fleroxacin.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with bromazepam.


The risk or severity of adverse effects can be increased when chloroquine is combined with paramethasone.


The risk or severity of adverse effects can be increased when cilnidipine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when oxycodone is combined with amitriptyline.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with ethosuximide.


The risk or severity of adverse effects can be increased when nalbuphine is combined with dibucaine.


The risk or severity of adverse effects can be increased when thiamylal is combined with promethazine.


The risk or severity of adverse effects can be increased when thiamylal is combined with clonazepam.


The risk or severity of adverse effects can be increased when diflunisal is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when rescinnamine is combined with fenoprofen.


The risk or severity of adverse effects can be increased when cetirizine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with selegiline.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with haloperidol.


The risk or severity of adverse effects can be increased when Lurasidone is combined with zonisamide.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with tizanidine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with ondansetron.


The risk or severity of adverse effects can be increased when Lurasidone is combined with tiagabine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with cocaine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Desloratadine is combined with citalopram.


The risk or severity of adverse effects can be increased when methazolamide is combined with dorzolamide.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when bupivacaine is combined with sulpiride.


The risk or severity of adverse effects can be increased when bupivacaine is combined with nimodipine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Pipamperone is combined with quinapril.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with mefloquine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with bupivacaine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with bumetanide.


The risk or severity of adverse effects can be increased when Droxicam is combined with loteprednol.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when clorazepate is combined with doxepin.


The risk or severity of adverse effects can be increased when Trospium is combined with topiramate.


The risk or severity of adverse effects can be increased when Toloxatone is combined with hydromorphone.


The risk or severity of adverse effects can be increased when acemetacin is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when Difenoxin is combined with citalopram.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when nimodipine is combined with quetiapine.


The risk or severity of adverse effects can be increased when estazolam is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when glutethimide is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with DESONIDE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when doxylamine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when glutethimide is combined with amisulpride.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when tolterodine is combined with HEROIN.


The risk or severity of adverse effects can be increased when Asenapine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with enflurane.


The risk or severity of adverse effects can be increased when meperidine is combined with prilocaine.


The risk or severity of adverse effects can be increased when meperidine is combined with isoflurane.


The risk or severity of adverse effects can be increased when meperidine is combined with ethotoin.


The risk or severity of adverse effects can be increased when Apremilast is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with oxyphenonium.


The risk or severity of adverse effects can be increased when risperidone is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when levodopa is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with flunarizine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Milnacipran.


The risk or severity of adverse effects can be increased when pimozide is combined with Difenoxin.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with DESONIDE.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when oxaprozin is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Rotigotine is combined with cilazapril.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with meclizine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with diltiazem.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when valsartan is combined with labetalol.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when valsartan is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when diflunisal is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when oxprenolol is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when fosinopril is combined with nifedipine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when oxaprozin is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when Ramelteon is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Ramelteon is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when fosinopril is combined with papaverine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when benzocaine is combined with trimipramine.


The risk or severity of adverse effects can be increased when methylene blue is combined with domperidone.


The risk or severity of adverse effects can be increased when sertraline is combined with mirtazapine.


The risk or severity of adverse effects can be increased when dyclonine is combined with primidone.


The risk or severity of adverse effects can be increased when estazolam is combined with felbamate.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with decamethonium.


The risk or severity of adverse effects can be increased when calcium lactate is combined with Paricalcitol.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with Demecarium.


The risk or severity of adverse effects can be increased when Rufinamide is combined with thalidomide.


The risk or severity of adverse effects can be increased when imipramine is combined with tiagabine.


The risk or severity of adverse effects can be increased when mesalamine is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with trandolapril.


The risk or severity of adverse effects can be increased when triprolidine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when baclofen is combined with Milnacipran.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with theobromine.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with nitric oxide.


The risk or severity of adverse effects can be increased when Milnacipran is combined with AMPHETAMINE.


The risk or severity of adverse effects can be increased when felodipine is combined with quetiapine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with flunarizine.


The risk or severity of adverse effects can be increased when zaleplon is combined with topiramate.


The risk or severity of adverse effects can be increased when nitrazepam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when oxazepam is combined with flunarizine.


The risk or severity of adverse effects can be increased when oxazepam is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when oxazepam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when phenobarbital is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when zotepine is combined with doxepin.


The risk or severity of adverse effects can be increased when Bortezomib is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when diflorasone is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when acebutolol is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with ifosfamide.


The risk or severity of adverse effects can be increased when imipramine is combined with zonisamide.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with nimodipine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with primidone.


The risk or severity of adverse effects can be increased when tropicamide is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with moclobemide.


The risk or severity of adverse effects can be increased when carbamazepine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with digitoxin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when apraclonidine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when carbamazepine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Tapentadol.


The risk or severity of adverse effects can be increased when diazepam is combined with Etidocaine.


The risk or severity of adverse effects can be increased when indomethacin is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when indomethacin is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when Pramocaine is combined with promethazine.


The risk or severity of adverse effects can be increased when ketamine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when secobarbital is combined with promethazine.


The risk or severity of adverse effects can be increased when secobarbital is combined with clonazepam.


The risk or severity of adverse effects can be increased when amisulpride is combined with felbamate.


The risk or severity of adverse effects can be increased when felbamate is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when doxepin is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Agomelatine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when sumatriptan is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when codeine is combined with sulpiride.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with ketoprofen.


The risk or severity of adverse effects can be increased when temazepam is combined with baclofen.


The risk or severity of adverse effects can be increased when fluoxetine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when PRIMAQUINE is combined with prilocaine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Pramocaine.


The risk or severity of adverse effects can be increased when antipyrine is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when sumatriptan is combined with promethazine.


The risk or severity of adverse effects can be increased when temazepam is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with triamcinolone.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when pergolide is combined with rabeprazole.


The risk or severity of adverse effects can be increased when pergolide is combined with bicalutamide.


The risk or severity of adverse effects can be increased when Torasemide is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Olsalazine is combined with Ditazole.


The risk or severity of adverse effects can be increased when temazepam is combined with prazepam.


The risk or severity of adverse effects can be increased when temazepam is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with clonidine.


The risk or severity of adverse effects can be increased when glutethimide is combined with methocarbamol.


The risk or severity of adverse effects can be increased when zotepine is combined with clidinium.


The risk or severity of adverse effects can be increased when glutethimide is combined with triprolidine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with carisoprodol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with sulpiride.


The risk or severity of adverse effects can be increased when butabarbital is combined with clozapine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with nimodipine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when fluoxetine is combined with protriptyline.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Metixene is combined with HEROIN.


The risk or severity of adverse effects can be increased when celecoxib is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when desipramine is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when Perospirone is combined with felbamate.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Flupentixol.


The risk or severity of adverse effects can be increased when nabumetone is combined with epirizole.


The risk or severity of adverse effects can be increased when oxazepam is combined with trazodone.


The risk or severity of adverse effects can be increased when meperidine is combined with efavirenz.


The risk or severity of adverse effects can be increased when ketoprofen is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when benazepril is combined with Nebivolol.


The risk or severity of adverse effects can be increased when reserpine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when Sacubitril is combined with metoprolol.


The risk or severity of adverse effects can be increased when thiopental is combined with amisulpride.


The risk or severity of adverse effects can be increased when prazosin is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Perospirone is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when felbamate is combined with desipramine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with diflunisal.


The risk or severity of adverse effects can be increased when ramipril is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when prazosin is combined with trandolapril.


The risk or severity of adverse effects can be increased when ramipril is combined with felodipine.


The risk or severity of adverse effects can be increased when ramipril is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with desoximetasone.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with trandolapril.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with felbamate.


The risk or severity of adverse effects can be increased when clozapine is combined with methazolamide.


The risk or severity of adverse effects can be increased when clozapine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with acetyldigitoxin.


The risk or severity of adverse effects can be increased when captopril is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when clozapine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Vecuronium is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with tubocurarine.


The risk or severity of adverse effects can be increased when fenofibrate is combined with atorvastatin.


The risk or severity of adverse effects can be increased when lorazepam is combined with zonisamide.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Drospirenone.


The risk or severity of adverse effects can be increased when epinephrine is combined with benzphetamine.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when epinephrine is combined with ritodrine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with tetracaine.


The risk or severity of adverse effects can be increased when mesalamine is combined with methazolamide.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with medrysone.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when methadone is combined with ketamine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Riociguat.


The risk or severity of adverse effects can be increased when sulconazole is combined with bepridil.


The risk or severity of adverse effects can be increased when Olopatadine is combined with flunarizine.


The risk or severity of adverse effects can be increased when zaleplon is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Sacubitril is combined with sotalol.


The risk or severity of adverse effects can be increased when amphotericin b is combined with digitoxin.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with phenytoin.


The risk or severity of adverse effects can be increased when Sacubitril is combined with brimonidine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Sacubitril is combined with celecoxib.


The risk or severity of adverse effects can be increased when Articaine is combined with brotizolam.


The risk or severity of adverse effects can be increased when secobarbital is combined with fludiazepam.